FHPI HCL
Synonym(s):4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole monohydrochloride hydrate;4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole, HCl, p38 MAP Kinase Inhibitor II, Hydrochloride;4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol monohydrochloride hydrate;SB 202190, Hydrochloride - CAS 350228-36-3 - Calbiochem
- CAS NO.:350228-36-3
- Empirical Formula: C20H15ClFN3O
- Molecular Weight: 367.8
- MDL number: MFCD01862621
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-03-13 15:00:32
What is FHPI HCL?
The Uses of FHPI HCL
The water soluble form of SB 202190, a highly selective, potent inhibitor of p38 MAP kinase. SB-202190 is able to promote proliferation of C6 cells in lower concentration but induced apoptosis in high er levels. Studies show that SB202190 can protect neural function from ischemia/reperfusion injury and regulate the activation of Bcl-2 and Bax protein after ischemia/reperfusion in rat.
The Uses of FHPI HCL
The water soluble form of SB 202190, a highly selective, potent inhibitor of p38 MAP kinase. SB-202190 is able to promote proliferation of C6 cells in lower concentration but induced apoptosis in higher levels. Studies show that SB202190 can protect neural function from ischemia/reperfusion injury and regulate the activation of Bcl-2 and Bax protein after ischemia/reperfusion in rat.
What are the applications of Application
SB202190 hydrochloride is an inhibitor of the isoforms p38α and p38&beta
General Description
A water-soluble form of the potent p38 MAP kinase inhibitor SB 202190 (Cat. No. 559388).
Biochem/physiol Actions
SB 202190 monohydrochloride hydrate mediates the phosphorylation of serine in the mutant p53 protein and modulates cell adhesion and prevents cell proliferation in breast cancer cell lines.
Properties of FHPI HCL
| storage temp. | -20°C |
| solubility | DMSO: ≥12mg/mL |
| form | solid |
| color | white to beige |
Safety information for FHPI HCL
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for FHPI HCL
New Products
2,6-Piperidinedione, 3-hydroxy-1-[(4-methoxyphenyl)methyl]- 3-(4-bromo-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione 4-Hydroxy-6-methyl-1-(4-methylphenyl)-2-naphthalenecarboxylic acid 2,3-Difluoro-6-methoxybenzyl Chloride KT-474 2-(6-(benzyloxy)-3,4-dihydronaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 3-Oxocyclobutanecarboxylic acid 5-Bromo-2-iodo pyridine Benzofuran-6-carboxylic acid (BFA) 3-Bromo-2-Ethoxy-5-Nitropyridine 3,6-Dichloro-2-Methylpyridine 2-Amino-5-Bromo-3-IodopyridineRelated products of tetrahydrofuran








You may like
-
SB202190 HCl >95% CAS 350228-36-3View Details
350228-36-3 -
SB 202190 monohydrochloride hydrate CAS 350228-36-3View Details
350228-36-3 -
5-Bromo-3-Methyl-2-Pyridinecarboxylic acid 886365-43-1 99%View Details
886365-43-1 -
186593-42-0 99%View Details
186593-42-0 -
2-Amino-4-Methylpyridine 99%View Details
695-34-1 -
370104-72-6 99%View Details
370104-72-6 -
4-Aminopyridine 99%View Details
504-24-5 -
4-dimethylaminopyridine ?1122-58-3 99%View Details
?1122-58-3

